Hemostemix Inc. (TSXV:HEM)
Canada · Delayed Price · Currency is CAD 0.0850
-0.0050 (-5.56%)
At close: Feb 27, 2026
Hemostemix Market Cap
Hemostemix has a market cap or net worth of CAD 16.6 million as of March 2, 2026. Its market cap has decreased by -56.20% in one year.
Market Cap
16.60M
Enterprise Value
18.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since November 28, 2014, Hemostemix's market cap has decreased from 48.88M to 16.60M, a decrease of -66.05%. That is a compound annual growth rate of -9.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 16.60M | -5.56% |
| Dec 31, 2025 | 17.57M | 3.39% |
| Dec 31, 2024 | 17.00M | 178.71% |
| Dec 29, 2023 | 6.10M | -55.27% |
| Dec 30, 2022 | 13.63M | 44.06% |
| Dec 31, 2021 | 9.46M | -70.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 33.25M |
| Telescope Innovations | 28.69M |
| Thiogenesis Therapeutics | 27.99M |
| Rapid Dose Therapeutics | 20.28M |
| Quantum BioPharma | 18.60M |
| Britannia Life Sciences | 16.23M |
| Lobe Sciences | 16.17M |
| Innovotech | 13.52M |